UK extends high-street eyecare scope - a diagnostic/surgical opportunity?:
This article was originally published in Clinica
Executive Summary
UK optometrists have welcomed the government's approval of plans to extend prescribing to high-street eyecare providers as promising a developing role in the specialism. "Allowing optometrists to prescribe independently will complement their existing diagnostic skills and further develop their role in the management of eye disease," said Kevin Lewis, president of the College of Optometrists. The new prescribing powers, which are backed by the General Optical Council, were the subject of a consultation that ended in October 2006. The College of Optometrists is heading the development of new clinical management guidelines for the specialism.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.